Jonathan Harris Speaks on In Re Rosuvastatin Litigation: Axinn Veltrop & Harkrider LLP

Speaking Engagements & Seminars

Jonathan Harris Speaks on In Re Rosuvastatin Litigation

On June 3, 2010, Jonathan Harris conducted a conference call sponsored by Barclays International to discuss the paragraph IV patent litigation In Re Rosuvastatin Litigation. After analyzing key evidence in the case, Jonathan provided his insights into the hotly contested issue of inequitable conduct.

AVH: One of only a handful of firms named to the National Law Journal's "Mid-size Hot List"

World Class: Founded by three lawyers from Skadden, Arps who were quickly joined by other lawyers who shared a common vision, both from government and from other firms such as Dewey & LeBoeuf, Sullivan & Cromwell and Simpson Thacher.

Unsurpassed Reputation: Our attorneys have handled some of the largest and most challenging antitrust matters in recent years, including the largest cash merger in U.S. history and a wide array of cutting-edge litigation and counseling matters.

Our industry focus includes:

Biomedical Biotechnology Medical Devices Pharmaceuticals Chemistry/Chemical Engineering Computer Software and Systems Mechanical

Unique Value: We understand the particular business goals of our clients, the nuances of the law and the strategies needed to exploit the technical subject matter at issue.

Track Record: All of the firm's lawyers are accomplished litigators who bring to every case an effective combination of general litigation skills, such as persuasive advocacy and procedural tactics, and experience in particular areas of the law.

AVH attorneys are thought leaders in their areas of concentration. We are often quoted in trade journals, national media, and speak frequently at industry events.

Join Us: AVH has among its ranks some of the most talented antitrust, IP, and litigation and regulatory attorneys in the country.

Attorneys